GlassScriptPhysician profile
Angela Harner
NPI 1851067334
$15,599.45
in general payments reported to CMS, 2019-2025
60 companies · $4,263 in 2025
The $4,263 reported for 2025 was more than what 98% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $238 · 2022: $2,846 · 2023: $3,396 · 2024: $4,856 · 2025: $4,263.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $12K · Consulting Fee: $200 · Travel and Lodging: $24.60.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $12,290.48 |
| Consulting Fee | $200.00 |
| Travel and Lodging | $24.60 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $2,504.08 | 2021-2025 | |
| Lilly USA, LLC | $1,165.50 | 2022-2025 | Amyvid, Emgality, Kisunla |
| Biogen, INC. | $1,095.77 | 2021-2025 | Tysabri, Vumerity, Leqembi |
| Novartis Pharmaceuticals Corporation | $1,032.83 | 2022-2025 | |
| Lundbeck LLC | $889.09 | 2022-2025 | Vyepti, Rexulti |
| Emd Serono, INC. | $881.31 | 2022-2025 | Mavenclad |
| Pfizer INC. | $699.14 | 2023-2025 | |
| Biohaven Pharmaceutical Holding Company LTD. | $623.13 | 2022 | |
| Jazz Pharmaceuticals INC. | $594.00 | 2022-2025 | |
| Harmony Biosciences LLC | $515.48 | 2022-2025 | Wakix |
| Axsome Therapeutics, INC. | $474.83 | 2023-2025 | Sunosi, Symbravo |
| Impel Pharmaceuticals INC. | $464.03 | 2022-2023 | Trudhesa |
| Ucb, INC. | $343.92 | 2023-2025 | Rystiggo, Nayzilam, Zilbrysq |
| Amneal Pharmaceuticals LLC | $322.92 | 2022-2025 | Rytary, Ongentys 50mg Capsules 30, Crexont |
| Teva Pharmaceuticals USA, INC. | $300.58 | 2022-2025 | Austedo, Austedo Xr, Ajovy |
Show all 60 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Avadel Cns Pharmaceuticals, LLC | $261.61 | 2024-2025 | Lumryz |
| Eisai INC. | $260.67 | 2023-2025 | |
| Medtronic, INC. | $176.21 | 2023-2025 | Inceptiv, Percept PC Brainsense |
| Neurocrine Biosciences, INC. | $173.38 | 2023-2025 | Ingrezza |
| Inspire Medical Systems, INC. | $167.70 | 2023-2025 | Inspire |
| Neurelis, INC. | $164.94 | 2024-2025 | Valtoco |
| Csl Behring | $156.76 | 2024-2025 | Hizentra |
| Argenx US, INC. | $156.26 | 2022-2025 | Vyvgart Hytrulo, Vyvgart |
| Genentech USA, INC. | $147.93 | 2023-2024 | Ocrevus, Enspryng |
| Averitas Pharma INC. | $141.84 | 2023-2024 | Qutenza |
| Celgene Corporation | $140.13 | 2022-2025 | Zeposia |
| Collegium Pharmaceutical, INC. | $134.79 | 2022-2025 | Belbuca, Xtampza |
| Allergan, INC. | $130.86 | 2021-2022 | |
| Genzyme Corporation | $129.95 | 2022-2025 | |
| Abbott Laboratories | $98.31 | 2022 | |
| Tg Therapeutics, INC. | $95.32 | 2023 | |
| Ge Healthcare | $87.92 | 2023-2024 | |
| Grifols USA, LLC | $82.65 | 2024-2025 | Gamunex-C |
| Revance Therapeutics, INC. | $78.08 | 2024 | Daxxify |
| Kyowa Kirin, INC. | $75.55 | 2023-2024 | Nourianz |
| Tanabe Pharma America, INC. | $72.71 | 2024-2025 | Radicava |
| Idorsia Pharmaceuticals US INC | $69.33 | 2023-2025 | Quviviq, Quviviq |
| Supernus Pharmaceuticals, INC. | $60.24 | 2021-2022 | |
| Otsuka America Pharmaceutical, INC. | $59.09 | 2023-2024 | Rexulti |
| Novo Nordisk INC | $50.92 | 2022 | |
| Alexion Pharmaceuticals, INC. | $47.52 | 2023-2024 | Ultomiris |
| Sumitomo Pharma America, INC. | $44.31 | 2024 | Aptiom |
| Corium, LLC | $33.21 | 2023 | Adlarity |
| Catalyst Pharmaceuticals, INC. | $32.76 | 2025 | |
| Boston Scientific Corporation | $32.40 | 2023 | |
| Sk Life Science, INC. | $31.64 | 2025 | |
| Amgen INC. | $29.25 | 2022 | |
| Vanda Pharmaceuticals INC. | $28.66 | 2024 | Ponvory |
| Sandoz INC. | $26.78 | 2024 | |
| 3b Medical, INC. | $24.63 | 2025 | Luna |
| Noctrix Health, INC. | $24.60 | 2025 | Nidra |
| Octapharma USA, INC. | $22.54 | 2024 | Panzyga |
| Resmed Corp | $22.26 | 2023 | |
| Upsher-Smith Laboratories LLC | $21.10 | 2023 | |
| Avion Pharmaceuticals | $20.90 | 2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $17.17 | 2025 | Hyqvia |
| Astrazeneca Pharmaceuticals LP | $16.46 | 2025 | Wainua |
| Merz Pharmaceuticals, LLC | $16.04 | 2022 | |
| Acorda Therapeutics, INC | $13.89 | 2023 | Inbrija, Ampyra |
| Ipsen Biopharmaceuticals, INC | $13.57 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Angela Harner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.